Gene · 23765
Papers3,930
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,930
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Coexisting Conditions Modifying Phenotypes of Patients with 22q11.2 Deletion Syndrome. | Genes (Basel) | 2023 | 36980952 | PubTator, text mining | PubMed |
| Immunogenic Cell Death Associated Molecular Patterns and the Dual Role of IL17RA in Interstitial Cystitis/Bladder Pain Syndrome. | Biomolecules | 2023 | 36979355 | PubTator, text mining | PubMed |
| The Efficacy and Safety of Subcutaneous Ixekizumab for the Treatment of Axial Spondylarthritis: A Systematic Review and Meta-Analysis. | Cureus | 2023 | 36974243 | PubTator, text mining | PubMed |
| A real-world observational study of dupilumab treatment in adult patients with prurigo nodularis. | An Bras Dermatol | 2023 | 36966024 | PubTator, text mining | PubMed |
| Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review. | Signal Transduct Target Ther | 2023 | 36964133 | PubTator, text mining | PubMed |
| Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics. | J Nanobiotechnology | 2023 | 36944946 | PubTator, text mining | PubMed |
| Characterization of immunomodulatory factors and cells in bronchoalveolar lavage fluid for immune checkpoint inhibitor-related pneumonitis. | J Cancer Res Clin Oncol | 2023 | 36944820 | PubTator, text mining | PubMed |
| Identification of an immunogenic cell death-related gene signature predicts survival and sensitivity to immunotherapy in clear cell renal carcinoma. | Sci Rep | 2023 | 36932108 | PubTator, text mining | PubMed |
| Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved? | Dermatol Ther (Heidelb) | 2023 | 36929119 | PubTator, text mining | PubMed |
| Cellular rejuvenation: molecular mechanisms and potential therapeutic interventions for diseases. | Signal Transduct Target Ther | 2023 | 36918530 | PubTator, text mining | PubMed |
| Immune determinants of the pre-metastatic niche. | Cancer Cell | 2023 | 36917952 | PubTator, text mining | PubMed |
| An updated portrait of monocyte-macrophages in classical Hodgkin lymphoma. | Front Oncol | 2023 | 36910620 | PubTator, text mining | PubMed |
| Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis. | Int J Mol Sci | 2023 | 36902437 | PubTator, text mining | PubMed |
| Psoriatic Arthritis: Pathogenesis and Targeted Therapies. | Int J Mol Sci | 2023 | 36902329 | PubTator, text mining | PubMed |
| Th17/Treg Imbalance: Implications in Lung Inflammatory Diseases. | Int J Mol Sci | 2023 | 36902294 | PubTator, text mining | PubMed |
| Update on the Pathogenesis of the Hirschsprung-Associated Enterocolitis. | Int J Mol Sci | 2023 | 36902033 | PubTator, text mining | PubMed |
| The Two Faces of Immune-Related lncRNAs in Head and Neck Squamous Cell Carcinoma. | Cells | 2023 | 36899863 | PubTator, text mining | PubMed |
| Candida albicans-specific Th17 cell-mediated response contributes to alcohol-associated liver disease. | Cell Host Microbe | 2023 | 36893735 | PubTator, text mining | PubMed |
| Management of Infections in Psoriatic Patients Treated with Systemic Therapies: A Lesson from the Immunopathogenesis of Psoriasis. | Dermatol Pract Concept | 2023 | 36892377 | PubTator, text mining | PubMed |
| Based on network pharmacology and bioinformatics to analyze the mechanism of action of Astragalus membranaceus in the treatment of vitiligo and COVID-19. | Sci Rep | 2023 | 36890149 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23765/papers?page=33